CIK 0001651308 · Large accelerated filer
BeOne Medicines Ltd.
Sign in to watch- Ticker
- BEIGF
- Exchange
- Nasdaq, OTC
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 981209416
- Phone
- 41-616851900
- Business address
- C/O BEONE MEDICINES I GMBH, AESCHENGRABEN 27, 21ST FLOOR, BASEL, Switzerland, 4051
- Former names
- BeiGene, Ltd.
Securities
- ONC American Depositary Shares Nasdaq
- BEIGF Common stock OTC
- 10-Q Report Quarterly Report
- 8-K Event Results of operations · Other events
- 8-K Event Other events
- 8-K Event Other events
- 4 Open-market sale Chief Executive Officer sold 50,000 shares at an average $152.13 ($7,606,556)
- 8-K Event Other events
- 8-K Event Other events
- 4 Gift Director gave 33,410 shares (gift)
- 8-K Event Results of operations
- 8-K Event Other events
- 4 Other disposition Director disposed of 7,800 shares (other)
- 4 Other acquisition 10% owner acquired 7,800 shares (other)
- SC 13D/A Stake Beneficial Ownership Report
- 8-K Event Other events
- 4 Open-market sale Director sold 16,060 shares at an average $196.65 ($3,158,121)
- S-8 Other Securities Offered to Employees in Benefit Plans
- 10-Q Report Quarterly Report
- 8-K Event Results of operations · Other events
- 8-K Event Regulation FD disclosure
- 4/A Open-market sale Chief Financial Officer sold 317 shares at $158.50 ($50,245)
Page 28 of 64 · 1,278 filings